Abstract
Post-artesunate delayed hemolysis (PADH) occurred in 6 of 24 children treated with artesunate for severe malaria in the United States; however, severe hemolysis requiring hospitalization or transfusion was rare. In children in the United States treated with artesunate, counseling, and symptom monitoring may be preferred to weekly laboratory surveillance for PADH.
| Original language | English |
|---|---|
| Pages (from-to) | 533-536 |
| Number of pages | 4 |
| Journal | Journal of the Pediatric Infectious Diseases Society |
| Volume | 13 |
| Issue number | 10 |
| DOIs | |
| State | Published - 1 Oct 2024 |
| Externally published | Yes |
Keywords
- adverse drug reaction
- artesunate
- hemolytic anemia
- malaria
- pediatric
- post-artesunate delayed hemolysis
Fingerprint
Dive into the research topics of 'Post-Artesunate Delayed Hemolysis in Pediatric Malaria Patients in the United States'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver